Completed EUCTR 2009-012031-15
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Germany Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance.
Countries Germany, Romania
Sponsor Technische Universitaet Muenchen, vertreten durch das Klinikum rechts der Isar
Condition Schizophrenia Completed NCT01136772
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Palo Alto Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor New York State Psychiatric Institute
Condition Schizophrenia Completed NCT00499044
This summary needs review. Please check the official study record and contact the research team for details.
In Boston Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other From 18 Years to 65 Years
Countries United States
Sponsor North Suffolk Mental Health Association
Condition Schizophrenia Completed NCT02085447
This summary needs review. Please check the official study record and contact the research team for details.
In Cleveland Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral Over 18 Years
Countries United States
Sponsor University Hospitals Cleveland Medical Center
Condition Schizophrenia Completed NCT01952041
This summary needs review. Please check the official study record and contact the research team for details.
In Glen Oaks Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral Over 18 Years
Countries United States
Sponsor Dartmouth-Hitchcock Medical Center
Condition Schizophrenia Terminated NCT00701753
This summary needs review. Please check the official study record and contact the research team for details.
In Vancouver Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. From 19 Years to 65 Years
Countries Canada
Sponsor TheraGenetics Limited
Condition Schizophrenia Terminated NCT02476708
This summary needs review. Please check the official study record and contact the research team for details.
In New Haven Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other From 18 Years to 65 Years
Countries United States
Sponsor Yale University
Condition Schizophrenia Completed NCT00292409
This study is completed. It is testing aripiprazole for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT00156637
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Fayetteville Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 65 Years
Countries United States
Sponsor US Department of Veterans Affairs
Condition Schizophrenia Completed NCT03751488
This study is completed in the United States. It is testing Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® for schizophrenia.
Multiple locations, including Garden Grove Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Luye Pharma Group Ltd.
Condition Schizophrenia Completed NCT01193153
This study is completed in the United States, in Bulgaria, in India, .... It is testing efficacy of Paliperidone Palmitate for schizophrenia.
Multiple locations, including Garden Grove Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Bulgaria, India, ...
Sponsor Janssen Scientific Affairs, LLC
Condition Schizophrenia Completed NCT01292577
This summary needs review. Please check the official study record and contact the research team for details.
In Pittsburgh Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 55 Years
Countries United States
Sponsor University of Pittsburgh
Condition Schizophrenia 
